Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs
- PMID: 2367529
- PMCID: PMC54284
- DOI: 10.1073/pnas.87.13.5173
Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs
Abstract
Primary skin fibroblasts from hemophilic dogs were transduced by recombinant retrovirus (LNCdF9L) containing a canine factor IX cDNA. High levels of biologically active canine factor IX (1.0 micrograms per 10(6) cells per 24 hr) were secreted in the medium. The level of factor IX produced increased substantially if the cells were stimulated by basic fibroblast growth factor during infection. Additionally, we also report that endothelial cells transduced by this virus can produce high levels of biologically active factor IX. We propose that skin fibroblasts and endothelial cells from hemophilia B dogs may serve as potential venues for the development and testing of models for treatment of hemophilia B by retrovirally mediated gene replacement therapy.
Similar articles
-
Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes.Hum Gene Ther. 1994 Mar;5(3):313-22. doi: 10.1089/hum.1994.5.3-313. Hum Gene Ther. 1994. PMID: 8018746
-
Canine hemophilia B resulting from a point mutation with unusual consequences.Proc Natl Acad Sci U S A. 1989 Dec;86(24):10095-9. doi: 10.1073/pnas.86.24.10095. Proc Natl Acad Sci U S A. 1989. PMID: 2481310 Free PMC article.
-
Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.J Am Vet Med Assoc. 1997 Dec 1;211(11):1418-21. J Am Vet Med Assoc. 1997. PMID: 9394892
-
Gene therapy for hemophilia.Curr Opin Mol Ther. 1999 Aug;1(4):493-9. Curr Opin Mol Ther. 1999. PMID: 11713765 Review.
-
Gene therapy for hemophilia B: AAV-mediated transfer of the gene for coagulation factor IX to human muscle.Adv Exp Med Biol. 2001;489:45-57. doi: 10.1007/978-1-4615-1277-6_4. Adv Exp Med Biol. 2001. PMID: 11554590 Review. No abstract available.
Cited by
-
Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity.Blood Adv. 2021 Mar 9;5(5):1224-1238. doi: 10.1182/bloodadvances.2020004071. Blood Adv. 2021. PMID: 33646304 Free PMC article.
-
Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1401-5. doi: 10.1073/pnas.92.5.1401. Proc Natl Acad Sci U S A. 1995. PMID: 7877990 Free PMC article.
-
Adhesion and incorporation of lacZ-transduced endothelial cells into the intact capillary wall in the rat.Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12018-22. doi: 10.1073/pnas.89.24.12018. Proc Natl Acad Sci U S A. 1992. PMID: 1465433 Free PMC article.
-
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.ILAR J. 2009;50(2):144-67. doi: 10.1093/ilar.50.2.144. ILAR J. 2009. PMID: 19293459 Free PMC article. Review.
-
New nucleotide sequence data on the EMBL File Server.Nucleic Acids Res. 1990 Oct 25;18(20):6181-92. doi: 10.1093/nar/18.20.6181. Nucleic Acids Res. 1990. PMID: 2235527 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
